Active Pharmaceutical Ingredient

Rilpivirine — CAS 132907-72-3

Also known as: Edurant; TMC278; R278474

GMP Certified IP / BP / EP / USP Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) / Antiretroviral Aurangabad, India
Rilpivirine API Supplier Manufacturer Aurangabad Maharashtra India — Mediocon Inc
Rilpivirine IP / BP / EP / USP  |  GMP Certified  |  Mediocon Inc, Maharashtra, India
CAS No: 132907-72-3

Product Overview

Rilpivirine is a high-purity Active Pharmaceutical Ingredient (API) classified as a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) for HIV treatment. Mediocon Inc manufactures GMP-compliant Rilpivirine at its facility in Aurangabad, Maharashtra, India.

Therapeutic Applications
  • HIV-1 infection treatment in combination ART regimens
  • Treatment-naive HIV-1 infected adults
  • Single-tablet regimen components
  • Long-acting injectable antiretroviral formulations

Technical Specifications

ParameterSpecification
CAS Number132907-72-3
Molecular FormulaC₂₂H₁₈N₆
Molecular Weight366.42 g/mol
GradeIP / BP / EP / USP
CategoryNon-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) / Antiretroviral
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Batch NoRLP/24032026
Mfg DateMAR 2026
Exp DateFEB 2031
Packing25 kg HDPE drums / as per requirement

Quality & Compliance

  • GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
  • Full pharmacopoeial compliance: IP / BP / EP / USP standards
  • Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
  • Stringent in-process quality control at every manufacturing stage
  • HPLC purity testing and spectroscopic identification (IR, NMR)
  • Cold-chain and controlled-environment storage facilities available
  • Exported to 40+ countries with full regulatory support
💬
Mediocon AI
Hello 👋 How can I help you today?